161 related articles for article (PubMed ID: 7908196)
1. Clinical significance of measuring plasma concentrations of glutamine and glutamate in alcoholic liver diseases.
Tominaga T; Suzuki H; Mizuno H; Kouno M; Suzuki M; Kato Y; Sato A; Okabe K; Miyashita M
Alcohol Alcohol Suppl; 1993; 1A():103-9. PubMed ID: 7908196
[TBL] [Abstract][Full Text] [Related]
2. Plasma protein C as a marker of hepatocellular damage in alcoholic liver disease.
Kłoczko J; Mian M; Wojtukiewicz MZ; Babiuch L; Bielawiec M; Galar M
Haemostasis; 1992; 22(6):340-4. PubMed ID: 1362178
[TBL] [Abstract][Full Text] [Related]
3. Procollagen-type III peptide serum concentrations in alcoholic and non-alcoholic liver disease.
Monarca A; Petrini C; Perolini S; Pozzi F; Adelasco L; Natangelo R; Croce G
Ric Clin Lab; 1985; 15(2):167-71. PubMed ID: 4059796
[TBL] [Abstract][Full Text] [Related]
4. Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma.
Ohhira M; Ohtake T; Saito H; Ikuta K; Tanaka K; Tanabe H; Kawashima T; Fujimoto Y; Naraki T; Ono M; Kohgo Y
Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):67S-70S. PubMed ID: 10235282
[TBL] [Abstract][Full Text] [Related]
5. Plasma fibronectin concentrations in patients with liver diseases.
Gluud C; Dejgaard A; Clemmensen I
Scand J Clin Lab Invest; 1983 Oct; 43(6):533-7. PubMed ID: 6658370
[TBL] [Abstract][Full Text] [Related]
6. Significance of plasma glutathione determination in patients with alcoholic and non-alcoholic liver disease.
Shigesawa T; Sato C; Marumo F
J Gastroenterol Hepatol; 1992; 7(1):7-11. PubMed ID: 1543872
[TBL] [Abstract][Full Text] [Related]
7. Serum beta2-microglobulin in liver disease.
Hällgren R
Scand J Clin Lab Invest; 1979 Sep; 39(5):441-7. PubMed ID: 93302
[TBL] [Abstract][Full Text] [Related]
8. [Serum concentration of alpha 1-antitrypsin in various hepatic diseases].
Villamil F; Galli B; Sorroche P; Occello M; Gelpi J; Welz G
Medicina (B Aires); 1986; 46(2):139-42. PubMed ID: 3033426
[No Abstract] [Full Text] [Related]
9. [Influence of chronic alcoholism on plasma 25-hydroxycholecalciferol levels].
Paliard P; Dumeril B; Romand-Monnier M; Frederich A
Presse Med; 1983 Feb; 12(8):503-6. PubMed ID: 6219359
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of atrial natriuretic peptide in patients with chronic liver disease.
Kawasaki H; Uemasu J; Maeda N; Hirayama C; Kobayashi T; Sakurai H
Am J Gastroenterol; 1987 Aug; 82(8):727-31. PubMed ID: 3037881
[TBL] [Abstract][Full Text] [Related]
11. [Plasma levels of folate and vitamin B(12) in patients with chronic liver disease].
Muro N; Bujanda L; Sarasqueta C; Gil I; Hijona E; Cosme A; Arenas J; Elosegui ME; Sarasola M; Calpasoro J; Arenas JI
Gastroenterol Hepatol; 2010 Apr; 33(4):280-7. PubMed ID: 20206409
[TBL] [Abstract][Full Text] [Related]
12. The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma.
Kang KH; Kim JH; Kang SH; Lee BJ; Seo YS; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
Gut Liver; 2015 Mar; 9(2):224-30. PubMed ID: 25473073
[TBL] [Abstract][Full Text] [Related]
13. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
[TBL] [Abstract][Full Text] [Related]
14. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay.
Fukui H; Brauner B; Bode JC; Bode C
J Hepatol; 1991 Mar; 12(2):162-9. PubMed ID: 2050995
[TBL] [Abstract][Full Text] [Related]
15. [Serum gamma glutamyl transpeptidase in hepatobiliary diseases. Comparison with alkaline phosphatase and aryl amidase].
Schlaeger R; Schenzer R; Kattermann R
Med Klin; 1972 Apr; 67(15):521-6. PubMed ID: 4340792
[No Abstract] [Full Text] [Related]
16. [Plasma prekallikrein in chronic liver diseases].
Ciechanowicz A; Miks B; Kawiak J; Ciechanowski K; Ryszkiewicz D; Długosz A; Syczewska-Wawrzynowicz M; Marzecka J; Czekalski S
Pol Arch Med Wewn; 1995 Nov; 94(5):395-401. PubMed ID: 8833936
[TBL] [Abstract][Full Text] [Related]
17. Serum procollagen III peptide in alcoholic and other chronic liver diseases.
Bell H; Raknerud N; Orjasaeter H; Haug E
Scand J Gastroenterol; 1989 Dec; 24(10):1217-22. PubMed ID: 2602904
[TBL] [Abstract][Full Text] [Related]
18. Serum carbohydrate-deficient transferrin in patients with nonalcoholic liver disease and with hepatocellular carcinoma.
Murawaki Y; Sugisaki H; Yuasa I; Kawasaki H
Clin Chim Acta; 1997 Mar; 259(1-2):97-108. PubMed ID: 9086297
[TBL] [Abstract][Full Text] [Related]
19. Serum gamma-glutamyl transpeptidase: its clinical significance.
Pár A; Mestyán I; Kádas I; Balázs M; Gógl A
Acta Med Acad Sci Hung; 1976; 33(4):309-19. PubMed ID: 23644
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate-deficient transferrin in serum in patients with liver diseases.
Stibler H; Hultcrantz R
Alcohol Clin Exp Res; 1987 Oct; 11(5):468-73. PubMed ID: 3314562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
